Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-025-96157-6
O
Oğur Karhan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
38
Citations
3
h-index
0
i10-index
Oğur Karhan is an academic researcher from Harran University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Lung Cancer Research Studies & Cancer Diagnosis and Treatment. The author has an h-index of 3, co-authored 36 publications.
ORCID: 0000-0002-7140-8957Papers by this author
worksFactors Influencing HER2 Discordance in Nonmetastatic Breast Cancer and The Role of Neoadjuvant Therapy
2022 · Future Oncology · 3 citations
https://doi.org/10.2217/fon-2022-0198
Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study
2024 · Oncology · 1 citations
https://doi.org/10.1159/000542693
1523P Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1586
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat